Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
This can be verified via the MHRA's medicines database and the EMA's medicines register
We do not publish purity figures we cannot evidence
Avoid active breakouts, inflamed areas, open wounds, irritation and broken skin
Dose increase: at Day 16 inside the on phase, the dose steps from the low end to the high end of the range
503A Compounding Pharmacies: Pharmacies preparing for peptide compounding should consider: Identifying and vetting potential API suppliers to, among other things, gain a full understanding of the supply chain, including the identity, FDA registration status and GMP compliance of all parties involved (original manufacturer, any repackagers, etc.)
Apply directly to scarred areas, not just as an all-over treatment
